Clinical Characteristics and Outcomes of Diabetic Ketoacidosis in Patients With Type 2 Diabetes using SGLT2 Inhibitors.
Raya AlmazroueiBachar AfandiFatima AlKindiRomona GovenderSaif Al-ShamsiPublished in: Clinical medicine insights. Endocrinology and diabetes (2023)
SGLT2i related DKA is associated with lower blood glucose levels, lower SBP, worse hypovolemia, increased risk of AKI, and longer hospital stay when compared to non SGLT2i related episodes. Since the benefits of SGLT2 inhibitors far outweigh potential risks, there is a need to raise healthcare professionals and patients' awareness about this potential association.
Keyphrases
- blood glucose
- end stage renal disease
- human health
- chronic kidney disease
- newly diagnosed
- ejection fraction
- type diabetes
- acute kidney injury
- glycemic control
- prognostic factors
- healthcare
- peritoneal dialysis
- risk assessment
- metabolic syndrome
- climate change
- weight loss
- patient reported outcomes
- acute care
- skeletal muscle
- patient reported